Dykema (Cannabis Law Blog)

APRIL 20, 2023

These legal guidelines/laws related to cannabis continue to be enacted, repealed, and debated in the Texas Legislature today, evidencing strong public sentiment for more accepted, legally permissible uses of cannabis and cannabis products. [ii] Health & Safety Code § 487.001 et seq. Specifically, H.B.

Law 74

Law Chronic Pain Conditions Medicine 74

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

DECEMBER 3, 2021

Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. Safety findings from this OLE analysis are consistent with the safety in the double-blind phase as well as the known safety profile of gananxolone.

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

JULY 30, 2019

Cannabidiol-based treatment receives marketing approval from EMA. The cannabidiol-based treatment Epidiolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel for use as an additional treatment for two types of seizures.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

The Blunt Truth

DECEMBER 3, 2019

In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly. Additionally, class actions continue to populate the federal docket based on third-party testing revealing that CBD supplements are not as advertised, only bolstering the FDA’s safety concerns.

Safety 68

Safety CBD Seed-To-Sale Food 68

Cannabis Law Report

AUGUST 23, 2021

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. The treatment was generally well tolerated and the median reduction in seizures was 81.9%

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

CannaMD

SEPTEMBER 15, 2020

What law legalized medical marijuana in Florida? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. How does Florida law define medical marijuana? So sit back, relax, and grab your notebook. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

MMJ Recs

MARCH 14, 2024

These conditions include, but are not limited to, cancer, epilepsy, multiple sclerosis, and PTSD, among others. Additionally, individuals experiencing severe pain, nausea, or muscle spasms are eligible for medical marijuana treatment. These standards encompass various aspects of testing, including potency, purity, and contaminants.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MARCH 6, 2024

From its historical origins to the present day, you’ll explore how attitudes, laws, and scientific advancements have shaped its acceptance. However, disparities between state and federal laws pose challenges, creating a complex regulatory landscape.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

MMJ Recs

DECEMBER 13, 2023

Legal Framework: Texas Compassionate Use Program Texas has historically maintained strict laws against the use of marijuana for both medicinal and recreational purposes. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

MMJ Recs

JANUARY 24, 2024

Michigan, a state at the forefront of progressive healthcare initiatives, has implemented its own Medical Marijuana Program for years now in order to implement alternative treatments into mainstream medical care. The regulatory framework encompasses licensing, cultivation, and distribution, emphasizing safety and accountability.

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

MMJ Recs

NOVEMBER 8, 2023

In recent years, a significant shift has occurred in Ohio’s approach to healthcare, with the introduction of medical marijuana (MMJ) marking a new era of treatment options for patients in the state. Stringent regulations govern the cultivation, processing, testing, and dispensing of MMJ products to guarantee their quality and safety.

Access 52

Access Chronic Pain Conditions Patients 52

MMJ Recs

JANUARY 15, 2024

Research has demonstrated the effectiveness of medical marijuana in treating conditions like multiple sclerosis, epilepsy , and certain cancer-related symptoms. By tapping into the therapeutic potential of marijuana, individuals in New Jersey can explore alternative and often more tolerable treatments for their health concerns.

Chronic Pain 52

Chronic Pain Marijuana Programs Conditions 52

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. These include, but are not limited to, cancer, glaucoma, HIV/AIDS, Parkinson’s disease, and epilepsy.

Dispensary 52

Dispensary Marijuana Strains Patients 52

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Effective, most effective in treatment Relieve symptoms. Today (30 May) at 09.30

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

MMJ Recs

NOVEMBER 11, 2020

This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment. Medical marijuana is now proven beyond doubt to be a very effective treatment for a whole host of painful and debilitating conditions. Medical Marijuana Laws In 2021.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

PrestoDoctor

AUGUST 2, 2023

In the state of Iowa, obtaining a medical cannabis card is a pathway towards accessing this alternative form of treatment legally and safely. Conditions include chronic pain, epilepsy, multiple sclerosis, cancer, and post-traumatic stress disorder (PTSD). The benefits of medical cannabis are vast and diverse.

Conditions 52

Conditions Epilepsy Dispensary Patients 52

Cannabis Law Report

MAY 30, 2022

Publisher: Law Now. If a rule of criminal law precludes a person from obtaining appropriate medical treatment when his or her life or health is in danger, then the state has intervened and this intervention constitutes a violation of that man’s or that woman’s security of the person …. These users were exempted from the law.

Marijuana 98

Marijuana Cultivation Treatment Consumption 98

Veriheal

JANUARY 18, 2023

Despite the law’s passing, CBD is still widely unregulated in the United Kingdom. The lack of regulation has raised concerns about consumer safety. This rare type of epilepsy caused her to endure up to 300 grand mal seizures per week from the tender age of five. CBD producers must obtain a valid license from the U.K.

CBD 79

CBD Strains Research and Development Oil 79

The Joint Blog

MARCH 21, 2021

CBD oil can be used in all sorts of ways, but it is most commonly associated with the treatment of various medical conditions. There is evidence out there to suggest that CBD oil can be used to treat the following conditions: Epilepsy. Here is a closer look at UK CBD laws: CBD grown in the UK must contain only trace amounts of THC.

Safety 26

Safety CBD Oil Cannabinoids 26

MJ Business Attorneys

OCTOBER 26, 2017

Lisa Pittman is one of the first attorneys in Texas to specialize in medical marijuana law. She came to the industry not from the recreational side, but as a mother seeking treatment for her child with epilepsy. How did you come to specialize in marijuana law? What did your law firm see in Texas?

Epilepsy 100

Epilepsy Recreational Treatment Programs 100

Veriheal

MARCH 31, 2023

All that being said, the study also uncovered a few symptoms that were not improved by the cannabis treatment. While the study’s findings are promising, researchers say that more studies are necessary to evaluate the efficacy and safety of these cannabis treatments. What do you think of this Tourettes study’s findings?

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Cannabis Law Report

FEBRUARY 1, 2022

Medical cannabis and psychedelics are being increasingly recognised by health professionals for their superior safety and efficacy compared to conventional pharmaceuticals. Left unaddressed, the toll on society will come at a huge cost and result not only in a continuous spike of mental health disorders, but also in lost human capital wealth.

Pharmaceutical 52

Pharmaceutical Medicine Safety Epilepsy 52

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” Rules and Restrictions.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety. A: Qualifying medical conditions in Ohio include cancer, PTSD, chronic pain, epilepsy, and more.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JUNE 15, 2022

.” Thirty-eight states, including Ohio, currently allow cannabis for medical use when they are prescribed for conditions such as cancer, epilepsy, chronic pain and post-traumatic stress disorder. Alex Kreit of Cincinnati, Ohio, director of the Chase Center on Addiction Law and Policy at Northern Kentucky University. Attorney.

Chronic Pain 52

Chronic Pain Epilepsy Access Medicine 52

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. This would answer questions about safety and efficacy, they said.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

DECEMBER 22, 2019

Cannabis-based medicine is to be fast-tracked into the NHS , allowing thousands of people to be prescribed the drugs, including children with severe epilepsy. But it has become apparent that doctors are unwilling to take the responsibility without more evidence on the effects and safety. Source: [link].

Epilepsy 59

Epilepsy Medicine Treatment Pharmaceutical 59

Cannabis Law Report

NOVEMBER 24, 2019

Severe treatment-resistant epilepsy. Consider nabilone as an add-on treatment for adults (18 years and over) with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics. 1.4 Severe treatment-resistant epilepsy. Finding more information and committee details. Spasticity.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. If the doctor determines that medical cannabis is a suitable treatment option, they will provide a recommendation for the patient. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

AUGUST 24, 2019

The report reveals… MGC Pharmaceuticals is set to kick off a controlled trial to discover if its medical cannabis product for the treatment of drug-resistant epilepsy has any impact on driving performance.

Epilepsy 45

Epilepsy Pharmaceutical Data Safety 45